• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume10, Issue4

A cross sectional study of prevalence of hearing impairment and tinnitus in type 2 diabetes mellitus patients

    Sharmila Dhulipalla, Anusha Makkena, Bhattiprolu Gowthami, Botsa Sravani

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 4, Pages 976-982

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

To assess prevalance of hearing loss and tinnitus among Diabetes mellitus type 2 patients in the cross-sectional study.
Materials and Methods: 120 patients were divided into groups based on their age, gender, the duration of their diabetes mellitus (10 years), and the types of diabetic medications they were using. In a soundproof room, thorough otoscopy examinations of their ears were performed, along with the tuning fork test, PTA, and other tests. A questionnaire was used to assess tinnitus.
Results: The total no.of diabetic patients considered for this study are 120. Out of which, 76 patients were identified with sensorineural hearing loss (SNHL). In these SHNL patients,48 were identified with mild SNHL(63.15%), 22 patients with moderate SNHL(28.94%), 2 with moderate severe SNHL(2.63%) and 4 patients with severe SNHL (5.26%).Tinnitus is seen in 35 patients (29.16%).The association of age (p=0.21) and sex (p=0.58) with Hearing loss (HL) and tinnitus were not statistically significant. Nevertheless, the duration of diabetes mellitus in relation to these ailments were statistically significant (p=0.07).
Conclusion: The patients with Diabetic mellitus were having higher degree of hearing threshold with B/L mild to moderate SNHL. Age and Gender of diabetic mellitus patients had no major correlation with HL and tinnitus. While the duration had major correlation with HL and tinnitus. These results infer that there is more prevalence of hearing impairment and tinnitus and develop at an earlier age in type 2 diabetes patients
Keywords:
    Diabetes hearing loss tinnitus
  • PDF (233 K)
  • XML
(2023). A cross sectional study of prevalence of hearing impairment and tinnitus in type 2 diabetes mellitus patients. European Journal of Molecular & Clinical Medicine, 10(4), 976-982.
Sharmila Dhulipalla, Anusha Makkena, Bhattiprolu Gowthami, Botsa Sravani. "A cross sectional study of prevalence of hearing impairment and tinnitus in type 2 diabetes mellitus patients". European Journal of Molecular & Clinical Medicine, 10, 4, 2023, 976-982.
(2023). 'A cross sectional study of prevalence of hearing impairment and tinnitus in type 2 diabetes mellitus patients', European Journal of Molecular & Clinical Medicine, 10(4), pp. 976-982.
A cross sectional study of prevalence of hearing impairment and tinnitus in type 2 diabetes mellitus patients. European Journal of Molecular & Clinical Medicine, 2023; 10(4): 976-982.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 16
  • PDF Download: 25
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus